An in vitro fertilisation routine aims to perfectly time the readiness of the endometrium and the placement of the embryo. Unfortunately, this timing is not always accurate, impairing implantation. That’s where endometrial receptivity analysis (ERA) comes in. ERA is a pathbreaking technology that helps embryologists to scientifically determine endometrial preparedness at a nanoscopic level. By performing an embryo transfer during the optimal endometrial window, the chances of implantation rise.
Endometrial receptivity analysis (ERA) is far ahead of other methods of endometrial assessment. Here’s how.
Endometrial readiness differs from woman to woman and predicting the ideal window for implantation can thus be challenging. ERA is a customised diagnostic tool that identifies a conducive window for implantation accurately.
Other diagnostic systems to assess endometrial viability hinge on structural variations in tissues, and their results display tremendous variance. ERA detects even slight molecular discrepancies, ensuring that every tiny detail is accounted for.
On Cloudnine, we recommend endometrial receptivity analysis (ERA) for guests who have a history of unsuccessful embryo implantation. Often, despite a spate of agreeable parameters like quality embryos, a healthy uterus and an adequate endometrial thickness, implantation fails to occur due to an ill-timed embryo transfer. ERA is also advisable for guests whose endometrial thickness fluctuates from cycle to cycle, not always touching the 6 millimetre benchmark.
An endometrial receptivity analysis (ERA) involves two main steps, which work in sync to provide insights to your fertility consultant about the health of your endometrium.
First, an endometrial biopsy is performed by your doctor, around the seventh day from the start of your menstrual cycle. The routine is conducted using a Pipelle catheter, and is simple and quick.
Once the biopsy is performed, your doctor will carefully examine the pattern of the 236 genes that play a role in endometrial readiness. A pioneering technology hosted exclusively on Cloudnine then sieves through the data to recognise whether the endometrium is receptive or not. Based on the output, your fertility consultant will discuss a treatment route with you.
The risks associated with endometrial receptivity analysis (ERA) are few and far between. Risks, if any, could be environmental, or posed by the procedures associated with ERA.
If ovulation is administered using inordinate amounts of medication, it could cause a condition called ovarian hyperstimulation syndrome. The condition can lead to a variety of symptoms such as severe abdominal pain, nausea, dark-tinted urine and breathlessness. On Cloudnine, we are particular about the course of medication we prescribe to every guest, creating a custom-made fertility plan that suits you and your body.
Any invasive procedure can give root to an infection, if not performed salubriously. Hygiene is one of our foremost priorities on Cloudnine with our sanitisation norms having set new trends in the Indian medical space. Our hospitals and equipment are thoroughly disinfected after every procedure.